Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP106868.RAatOQIt5xzIw5FS5ctc3u1Kwt5CnHm_CkYdT5L6gHv7U130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP106868.RAatOQIt5xzIw5FS5ctc3u1Kwt5CnHm_CkYdT5L6gHv7U130_provenance.
• NP111878.RARI_NOfFhCyWseEqQCWOsSsSXCax-qJwalBU7FwYfnUw130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111878.RARI_NOfFhCyWseEqQCWOsSsSXCax-qJwalBU7FwYfnUw130_provenance.
• NP111908.RAbeUJzAZtUm3k1d5-eZAVYL7PdtNAUg2aOiUu6FmvsCY130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111908.RAbeUJzAZtUm3k1d5-eZAVYL7PdtNAUg2aOiUu6FmvsCY130_provenance.
• NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111909.RAWee0N_G9bn7D8_iBaQL332bcp1WB6eFX-RXslaysmNA130_provenance.
• NP112014.RATJphS2rVRh-HmriSSTRUx5PKoaTp0DA4PP4wD3x4jpA130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP112014.RATJphS2rVRh-HmriSSTRUx5PKoaTp0DA4PP4wD3x4jpA130_provenance.
• NP105000.RAiDytG2WGVonq5nFiJmGcKzM_cjmyXKsVjQWU5vXA5F4130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105000.RAiDytG2WGVonq5nFiJmGcKzM_cjmyXKsVjQWU5vXA5F4130_provenance.
• NP105659.RAgGwxT_0GNfPZMR34s3Hdhzg8Nq31RpcLgGh2R12PkM8130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105659.RAgGwxT_0GNfPZMR34s3Hdhzg8Nq31RpcLgGh2R12PkM8130_provenance.
• NP106747.RAmyQhZZZnFgHzFi89_6zMyxfic6qNMMZBBmVY3xdvMjg130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP106747.RAmyQhZZZnFgHzFi89_6zMyxfic6qNMMZBBmVY3xdvMjg130_provenance.
• NP106869.RAuSM2BNR8NYljUrbP8nXiUXr757WPIKqJzB4h46PKS5U130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP106869.RAuSM2BNR8NYljUrbP8nXiUXr757WPIKqJzB4h46PKS5U130_provenance.
• NP106870.RAiGkqFZfG9ghUbdXduWKcdSW60W98VWBQOcXxYoTQbTI130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP106870.RAiGkqFZfG9ghUbdXduWKcdSW60W98VWBQOcXxYoTQbTI130_provenance.
• NP111473.RAqjqf1luMehCc6MW8zOpSbvxBoriQsm-g1U9DzF_LlUE130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111473.RAqjqf1luMehCc6MW8zOpSbvxBoriQsm-g1U9DzF_LlUE130_provenance.
• NP111758.RAlbkbGel3-OJu-zQCtR7caWsglwxm2oE4JwkqffnHf40130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111758.RAlbkbGel3-OJu-zQCtR7caWsglwxm2oE4JwkqffnHf40130_provenance.
• NP111759.RAhK0g5NydYDRpB9oPse5tcPSHaeEl6K4k9kLYEnhSPdU130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111759.RAhK0g5NydYDRpB9oPse5tcPSHaeEl6K4k9kLYEnhSPdU130_provenance.
• NP123379.RAfHigTs00NExyBVz093fS3FJgZ135Cuqx78VUOuxmj_M130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123379.RAfHigTs00NExyBVz093fS3FJgZ135Cuqx78VUOuxmj_M130_provenance.
• NP123381.RAd1hf6snNLkHF89U2Vblvqsb0OYs7ZBquKut_9cJrprY130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123381.RAd1hf6snNLkHF89U2Vblvqsb0OYs7ZBquKut_9cJrprY130_provenance.
• NP123383.RAYE0JWs-SqiQzypOr3s3dEB80QkIh6G7GIk9UAbSrqTI130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123383.RAYE0JWs-SqiQzypOr3s3dEB80QkIh6G7GIk9UAbSrqTI130_provenance.
• NP123386.RAdqQdeekY_oqB34vH7cxdJ6gSE7OYz5tCVZmRZSibpx8130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123386.RAdqQdeekY_oqB34vH7cxdJ6gSE7OYz5tCVZmRZSibpx8130_provenance.
• NP123389.RAbt0ndvxMa5hN3Tj2og-z7tUAspZikMClvzhdZjneZzg130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123389.RAbt0ndvxMa5hN3Tj2og-z7tUAspZikMClvzhdZjneZzg130_provenance.
• NP123395.RATKXoFUJCpqPDBvRImbAunrYtpQnF5HSLOSFUlztTtLo130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123395.RATKXoFUJCpqPDBvRImbAunrYtpQnF5HSLOSFUlztTtLo130_provenance.
• NP123397.RAVLGSLgeyS2qSiqo5PF4gRgj6ns2vJOe8cb6P1kRP0QQ130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123397.RAVLGSLgeyS2qSiqo5PF4gRgj6ns2vJOe8cb6P1kRP0QQ130_provenance.
• NP123400.RAXDGVfdd5zFxy2u4PE1eSLtEIteJY0A-pDMV82KlZHTI130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123400.RAXDGVfdd5zFxy2u4PE1eSLtEIteJY0A-pDMV82KlZHTI130_provenance.
• NP123402.RAf_4GAVTRttd3LQnmAgBGiIjXn59rTeG63v-f98yDpWs130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123402.RAf_4GAVTRttd3LQnmAgBGiIjXn59rTeG63v-f98yDpWs130_provenance.
• NP123404.RAcNEhpeJyeaNz0mDt3PyMdOGLNVgGexY79KnAg_t_MlM130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123404.RAcNEhpeJyeaNz0mDt3PyMdOGLNVgGexY79KnAg_t_MlM130_provenance.
• NP112018.RABYs4tGVjvHuAG4z0ZcOfWqvJ0twszGqkwnVLT90uwyc130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP112018.RABYs4tGVjvHuAG4z0ZcOfWqvJ0twszGqkwnVLT90uwyc130_provenance.
• NP105663.RAAn9knMw8tUbA8nGXRqdq_9OLeUBohUGPgfNZceEDuw8130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105663.RAAn9knMw8tUbA8nGXRqdq_9OLeUBohUGPgfNZceEDuw8130_provenance.
• NP123385.RADZSgzrDcU1XuLKfIvicz4y4Wk212lP3wevruwRAJh4A130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123385.RADZSgzrDcU1XuLKfIvicz4y4Wk212lP3wevruwRAJh4A130_provenance.
• NP123391.RAA2rcuo4C3I7JSOPTX8qDjCdLSKjYzzsSaUwi76A5Ih8130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123391.RAA2rcuo4C3I7JSOPTX8qDjCdLSKjYzzsSaUwi76A5Ih8130_provenance.
• NP123399.RADK2n5M1TgqENWVwP1bC2-DXshOXDOW2LMdnv_TdCr7U130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123399.RADK2n5M1TgqENWVwP1bC2-DXshOXDOW2LMdnv_TdCr7U130_provenance.
• NP123403.RADargWykYF2T_ZSQSNjxfEkdyzzbAxWGU7-YH11Qoh_g130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123403.RADargWykYF2T_ZSQSNjxfEkdyzzbAxWGU7-YH11Qoh_g130_provenance.
• NP123382.RAqN_p-ZIhENRrQbfYZ_p_xLgp_83EbCMGV64sz-UU7aE130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123382.RAqN_p-ZIhENRrQbfYZ_p_xLgp_83EbCMGV64sz-UU7aE130_provenance.
• NP123384.RArlcCUPKlFJaFuePfFBG2wOrTCUIS3lcof2qY7Q_5vbY130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123384.RArlcCUPKlFJaFuePfFBG2wOrTCUIS3lcof2qY7Q_5vbY130_provenance.
• NP123387.RAiN48SS7K3qNe2sVAiwMTJNzM6y8_f0trlRSawmfjRSo130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123387.RAiN48SS7K3qNe2sVAiwMTJNzM6y8_f0trlRSawmfjRSo130_provenance.
• NP123392.RAqOJ4KYUpesct09o7TD_o72EaHNbmXbhc-ZHPBjJDQvo130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123392.RAqOJ4KYUpesct09o7TD_o72EaHNbmXbhc-ZHPBjJDQvo130_provenance.
• NP123398.RAj3k20BaktE1kYKm6mS6vAyFZCjXf5n3yekAgqfDdYLI130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123398.RAj3k20BaktE1kYKm6mS6vAyFZCjXf5n3yekAgqfDdYLI130_provenance.
• NP123401.RAvoav7eapul28Cgi9O1zup2Q1sHxBafOz7tjpmMncY-0130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123401.RAvoav7eapul28Cgi9O1zup2Q1sHxBafOz7tjpmMncY-0130_provenance.
• NP123405.RAiH8MliwlLo81tDQ53oDGL2CXPBOgPijU4iXeoBJHOOU130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123405.RAiH8MliwlLo81tDQ53oDGL2CXPBOgPijU4iXeoBJHOOU130_provenance.
• NP105004.RA3i97Y59mwvbnfOsfjZVnxh83BZEoMWP2zSF2C9SvfAs130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105004.RA3i97Y59mwvbnfOsfjZVnxh83BZEoMWP2zSF2C9SvfAs130_provenance.
• NP106748.RA1hO-Iqd-OyqiIWNcim2945aAhStGFKxQrOAHu4EShZ4130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP106748.RA1hO-Iqd-OyqiIWNcim2945aAhStGFKxQrOAHu4EShZ4130_provenance.
• NP111410.RAyg-DkXcGadCnxge44EHqBFciSgZMw1KwV4y6UtXbsD0130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111410.RAyg-DkXcGadCnxge44EHqBFciSgZMw1KwV4y6UtXbsD0130_provenance.
• NP111414.RAzeUo-luE3ZJlo0g0ysumSxDub1aviJMINWI0P47VpfE130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111414.RAzeUo-luE3ZJlo0g0ysumSxDub1aviJMINWI0P47VpfE130_provenance.
• NP111471.RA0gILUQQlNN9HFMQAQhx7aJIEFSAKc4CsHmhnoqQFqVk130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111471.RA0gILUQQlNN9HFMQAQhx7aJIEFSAKc4CsHmhnoqQFqVk130_provenance.
• NP111760.RA6yZHFS8NQpEpffvFhZmK-811HcAExYQB2rFFqOfBkZY130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111760.RA6yZHFS8NQpEpffvFhZmK-811HcAExYQB2rFFqOfBkZY130_provenance.
• NP105006.RALlcjpAwo5G7G3qXyp7Ep2rriGxFHG3VeMNCrFcD6fjw130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105006.RALlcjpAwo5G7G3qXyp7Ep2rriGxFHG3VeMNCrFcD6fjw130_provenance.
• NP105661.RAFjH4vBVNPkPvZTQImwhs4kUtILi21Bil0waPHk-SEsU130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105661.RAFjH4vBVNPkPvZTQImwhs4kUtILi21Bil0waPHk-SEsU130_provenance.
• NP106749.RALkpGA7dLWYzz_enfGTwfA72KsHOpRWepXm4TN4Tpm-Q130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP106749.RALkpGA7dLWYzz_enfGTwfA72KsHOpRWepXm4TN4Tpm-Q130_provenance.
• NP111412.RAPu2aq1k0tul5lJ4T91qMq-hPDVExi3pT2iLwN48kYE8130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111412.RAPu2aq1k0tul5lJ4T91qMq-hPDVExi3pT2iLwN48kYE8130_provenance.
• NP111468.RAEJsKRDa65PJgEHVA_41UndGGHb4g5dZ6o2d6XPPa3zg130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111468.RAEJsKRDa65PJgEHVA_41UndGGHb4g5dZ6o2d6XPPa3zg130_provenance.
• NP112016.RAL0z5SeJzsfWxUtMaT97FxbdVnC_h2c51xuB8GCU10BU130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP112016.RAL0z5SeJzsfWxUtMaT97FxbdVnC_h2c51xuB8GCU10BU130_provenance.
• NP123388.RAH4fWTeLgM2lW23K_vBFR1xFJQOtPxnK361rfExgd-sM130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123388.RAH4fWTeLgM2lW23K_vBFR1xFJQOtPxnK361rfExgd-sM130_provenance.
• NP123390.RANhWX36qqaohiaLZj73XYVMjw_yBIirkysgRmqhLdt6k130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123390.RANhWX36qqaohiaLZj73XYVMjw_yBIirkysgRmqhLdt6k130_provenance.
• NP123396.RAFQNMG11eLvGbTcmC0FIbt5i-jutQEta-dq9tZqMcyb0130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123396.RAFQNMG11eLvGbTcmC0FIbt5i-jutQEta-dq9tZqMcyb0130_provenance.
• NP123380.RA22Ho1xdp2zHXZ8zxM00Dd2es64zk1oz9O2TtfLskOs8130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123380.RA22Ho1xdp2zHXZ8zxM00Dd2es64zk1oz9O2TtfLskOs8130_provenance.
• NP123393.RA9k7dAIXrWul7ii1Eqigf3VjZ9nqTO9Qh0R3KMyuUZD0130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123393.RA9k7dAIXrWul7ii1Eqigf3VjZ9nqTO9Qh0R3KMyuUZD0130_provenance.
• NP123394.RA6gG1egTlWhhAWGxo04PnnTJVe00aVYf7l3dTY0jIkoI130_assertion description "[Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123394.RA6gG1egTlWhhAWGxo04PnnTJVe00aVYf7l3dTY0jIkoI130_provenance.